High-resolution genotyping of the endemic Salmonella Typhi population during a Vi (typhoid) vaccination trial in Kolkata

PLoS Neglected Tropical Diseases

Volumn 6, Issue 1, 2012, Pages

  Holt, Kathryn E ^a   Dutta, Shanta ^b   Manna, Byomkesh ^b   Bhattacharya, Sujit K ^b   Bhaduri, Barnali ^b   Pickard, Derek J ^c   Ochiai, R Leon ^d   Ali, Mohammad ^d   Clemens, John D ^d   Dougan, Gordon ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; HEPATITIS A VACCINE; NALIDIXIC ACID; QUINOLONE; TYPHOID VACCINE; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; TYPHOID PARATYPHOID VACCINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BLOOD CULTURE; CLINICAL TRIAL; CONTROLLED STUDY; DNA EXTRACTION; ENDEMIC DISEASE; GENOTYPE; HAPLOTYPE; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PHENOTYPE; PHYLOGENY; POPULATION; POPULATION DIFFERENTIATION; POPULATION DISTRIBUTION; POPULATION STRUCTURE; SALMONELLA TYPHI; SINGLE NUCLEOTIDE POLYMORPHISM; TYPHOID FEVER; ANTIBIOTIC RESISTANCE; CLASSIFICATION; CLINICAL TRIAL (TOPIC); EPIDEMIC; GENETICS; INDIA; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; VACCINATION;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; INDIA; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; POLYMORPHISM, SINGLE NUCLEOTIDE; QUINOLONES; SALMONELLA TYPHI; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; VACCINATION;

EID: 84856587343     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001490     Document Type: Article

References (33)

1. Crump JA, Luby SP, Mintz ED, (2004) The global burden of typhoid fever. Bull World Health Organ 82: 346-353.
2. Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, et al. (2008) A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 86: 260-268.
3. Kothari A, Pruthi A, Chugh TD, (2008) The burden of enteric fever. J Infect Dev Ctries 2: 253-259.
4. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ, (2002) Typhoid fever. N Engl J Med 347: 1770-1782.
5. Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, et al. (2007) Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 51: 4315-4323.
6. Crump JA, Kretsinger K, Gay K, Hoekstra RM, Vugia DJ, et al. (2008) Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother 52: 1278-1284.
7. Wain J, Hoa NT, Chinh NT, Vinh H, Everett MJ, et al. (1997) Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 25: 1404-1410.
8. Sur D, von Seidlein L, Manna B, Dutta S, Deb AK, et al. (2006) The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study. Trans R Soc Trop Med Hyg 100: 725-733.
9. Karkey A, Arjyal A, Anders KL, Boni MF, Dongol S, et al. (2010) The burden and characteristics of enteric fever at a healthcare facility in a densely populated area of Kathmandu. PLoS One 5: e13988.
10. Fraser A, Paul M, Goldberg E, Acosta CJ, Leibovici L, (2007) Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine 25: 7848-7857.
11. Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, et al. (2009) A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med 361: 335-344.
12. Whitaker JA, Franco-Paredes C, del Rio C, Edupuganti S, (2009) Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas. J Travel Med 16: 46-52.
13. DeRoeck D, Ochiai RL, Yang J, Anh DD, Alag V, et al. (2008) Typhoid vaccination: the Asian experience. Expert Rev Vaccines 7: 547-560.
14. Kidgell C, Reichard U, Wain J, Linz B, Torpdahl M, et al. (2002) Salmonella typhi, the causative agent of typhoid fever, is approximately 50,000 years old. Infect Genet Evol 2: 39-45.
15. Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX, et al. (2008) High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet 40: 987-993.
16. Roumagnac P, Weill FX, Dolecek C, Baker S, Brisse S, et al. (2006) Evolutionary history of Salmonella typhi. Science 314: 1301-1304.
17. Baker S, Holt K, van de Vosse E, Roumagnac P, Whitehead S, et al. (2008) High-throughput genotyping of Salmonella enterica serovar Typhi allowing geographical assignment of haplotypes and pathotypes within an urban District of Jakarta, Indonesia. J Clin Microbiol 46: 1741-1746.
18. Holt KE, Baker S, Dongol S, Basnyat B, Adhikari N, et al. (2010) High-throughput bacterial SNP typing identifies distinct clusters of Salmonella Typhi causing typhoid in Nepalese children. BMC Infect Dis 10: 144.
19. Baker S, Holt K, Clements A, Karkey A, Arjyal A, et al. (2011) Combined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmission. Open Biol 1.
20. Holt K, Dolecek C, Chau T, Duy P, La TTP, et al. (2011) Temporal Fluctuation of Multidrug Resistant Salmonella Typhi Haplotypes in the Mekong River Delta Region of Vietnam. PloS Negl Trop Dis 5: e929.
21. Kariuki S, Revathi G, Kiiru J, Mengo DM, Mwituria J, et al. (2010) Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 48: 2171-2176.
22. Dutta S, Sur D, Manna B, Bhattacharya SK, Deen JL, et al. (2005) Rollback of Salmonella enterica serotype Typhi resistance to chloramphenicol and other antimicrobials in Kolkata, India. Antimicrob Agents Chemother 49: 1662-1663.
23. Dutta S, Sur D, Manna B, Sen B, Deb AK, et al. (2006) Evaluation of new-generation serologic tests for the diagnosis of typhoid fever: data from a community-based surveillance in Calcutta, India. Diagn Microbiol Infect Dis 56: 359-365.
24. Ali M, Sur D, Kim DR, Kanungo S, Bhattacharya SK, et al. (2011) Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India. Vaccine 29: 9051-9056.
25. Janis C, Grant AJ, McKinley TJ, Morgan FJ, John VF, et al. (2011) In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivo-inducible promoter. Infection and Immunity 79: 2481-2488.
26. Tran QT, Gomez G, Khare S, Lawhon SD, Raffatellu M, et al. (2010) The Salmonella enterica serotype Typhi Vi capsular antigen is expressed after the bacterium enters the ileal mucosa. Infection and immunity 78: 527-535.
27. Santander J, Roland KL, Curtiss R 3rd, (2008) Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi. J Infect Dev Ctries 2: 412-420.
28. Bopp CA, Brenner FW, Wells JG, Strockbine NA, (1999) Escherichia, shigella and salmonella. In: Murray PR, editors. Manual of Clinical Microbiology. 7 ed Washington, DC ASM Press pp. 459-474.
29. Clinical and Laboratory Standards Institute (2009) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Eighth Edition Pennsylvania, USA Clinical and Laboratory Standards Institute.
30. Hornick K, (2010) The R FAQ. Available:http://CRAN.R-project.org/doc/FAQ/R-FAQ.html.
31. Dutta S, Sur D, Manna B, Sen B, Bhattacharya M, et al. (2008) Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India. Int J Antimicrob Agents 31: 387-389.
32. Pearson T, Busch JD, Ravel J, Read TD, Rhoton SD, et al. (2004) Phylogenetic discovery bias in Bacillus anthracis using single-nucleotide polymorphisms from whole-genome sequencing. Proc Natl Acad Sci U S A 101: 13536-13541.
33. Holt KE, Phan MD, Baker S, Duy PT, Nga TV, et al. (2011) Emergence of a Globally Dominant IncHI1 Plasmid Type Associated with Multiple Drug Resistant Typhoid. PLoS Negl Trop Dis 5: e1245.